期刊文献+

体外培养骨髓单个核细胞分泌促血管生长因子的实验研究 被引量:2

Experimental study of angiogenin factors secreted by bone marrow mononuclear cells cultured in vitro
原文传递
导出
摘要 目的分析体外培养的骨髓单个核细胞持续分泌促血管生长因子的能力。方法从大鼠胫骨及股骨采集骨髓,密度梯度离心法分离出骨髓单个核细胞进行体外培养,并连续收集4周培养上清液。酶联免疫吸附实验(ELISA)法测定培养上清液中碱性成纤维细胞生长因子(bFGF)、血管内皮细胞生长因子(VEGF)和白介素-1β(IL-1β)等因子水平。结果第1、2、3、4周骨髓单个核细胞体外培养上清液中VEGF分别为(24.40±7.99)pg/m、l(89.28±5.13)pg/m、l(115.24±10.08)pg/m、l(157.00±15.64)pg/m l;bFGF含量分别为(52.72±2.13)pg/m、l(48.10±6.41)pg/m、l(44.71±3.21)pg/m、l(25.61±2.42)pg/m l;IL-1β含量分别为:(31.28±5.44)pg/m、l(71.87±3.01)pg/m、l(55.77±11.94)pg/m、l(41.75±9.14)pg/m。l结论体外培养骨髓单个核细胞可持续分泌VEGF、bFGF、IL-1β等多种促血管生长因子。 Objective To define the secretory capability of angiogenin factors by bone marrow mononuclear cells (BM-MNC) cultured in vitro. Methods Rat BM-MNCs were isolated by centrifugation through a Histopaque density gradient and cultured for four weeks in vitro. The levels of vascular endothelial cell growth factor (VEGF), basic fibroblast growth factor (bFGF) and interleukin-1β(IL-1β) were tested by enzyme - linked immunosorbent assay (ELISA). Results The levels of VEGF in the conditioned medium at 1,2, 3 and 4 weeks were (24. 40 ± 7.99), (89. 28 ± 5. 13 ), ( 115.24 ± 10. 08) and ( 157.00 ±15.64) pg/ml, respectively. The levels of bFGF at 1, 2, 3 and 4 weeks were (52. 72±2. 13), (48. 10±6. 41 ), (44. 71±3. 21 ) and (25.61±2. 42) pg/ml respectively, and those of IL-1β were (31.28±5.44), (71.87±3.01) , (55.77±11.94) and (41.75±9.14), respectively. Conclusion The BM-MNCs can persistently secrete potent angiogenie cytokines such as VEGF, bFGF and IL-1β.
出处 《中国医师杂志》 CAS 2006年第4期456-457,共2页 Journal of Chinese Physician
关键词 血管内皮生长因子类 成纤维细胞生长因子2 白细胞介素1 骨髓细胞 单核细胞 Vascular endothelial growth factors Fibroblast growth factor 2 Interleukin-1 Bone marrow cells Monocytes
  • 相关文献

参考文献11

  • 1Kobayashi T,Hamano K,Li TS,et al.Enhancement of angiogenesis by the implantation of self bone marrow cells in a rat ischemic heart model.J Surg Res,2000,89:189-195.
  • 2Hamano K,Li TS,Kobayashi T,et al.Angiogenesis induced by the implantationof self bone marrow cells:A new material for therapeutic angiogenesis.Cell Transplant,2000,9(23):439.
  • 3Tomita S,Li RK,Richard D,et al.Autolougous transplantation of bone marrow cells improves damaged heart function.Circulation,1999,199(supplⅡ):Ⅱ-247-Ⅱ-256.
  • 4Asahara T,Murohara T,Sullivan A,et al.Isolation of putative progenitor endothelial cells for angiogenesis.Science,1997,275:964-967.
  • 5Risau W.Mechanisms of angiogenesis.Nature,1997,386:671-674.
  • 6Ferrara N,Davis-Smyth T.The biology of vascular endothelial growth factor.Endocr Rev,1997,18(1):4-25.
  • 7Rifin DB,Moscatelli D.Resent developments in the cell biology of basic fibroblast growth factor.J Cell Biol,1989,109:1.
  • 8Prendergast RA,Luttv GA,Dinarello AC.Interleukin-1 induces corneal vacularization.Invest Opthalmol Vis Sci,1987,28:A400.
  • 9Holash J,Wiegand SJ,Yancopoulos GD.New model of tumor angiogenesis:dynamic balance between vessels regression and growth mediated by angiopoietins and VEGF.Oncogene,1999,18:5356-5362.
  • 10Epstein SE,Fuchs S,Zhou YF,et al.Therapeutic interventions for enhancing collateral development by administration of growth factors:basic principles,early results and potential hazards.Cardiovasc Res,2001,49:532-542.

同被引文献52

  • 1Lopez AD,Mathers CD,Ezzati M. Global and regional burden of disease and risk factors,2001:systematic analysis of population health data[J].{H}LANCET,2006,(9524):1747-1757.
  • 2Monteiro P,Antunes A,Goncalves LM. Long-term clinical impact of coronary-col ateral vessels after acute infarction[J].{H}Revista Portuguesa de Cardiologia,2003,(09):1051-1061.
  • 3Perez-Castel ano N,Garcia EJ,Abeytua M. Influence of col ateralcirculation on in-hospital death from anterior acute myocardial infarction[J].{H}Journal of the America College of Cardiology,1998,(03):512-518.
  • 4Kodama K,Kusuoka H,Sakai A. Col ateral channels that develop after an acute myocardial infarction prevent subsequent left ventricular dilation[J].{H}Journal of the America College of Cardiology,1996,(05):1133-1139.
  • 5Fukuda K,Yuasa S. Stem cel s as a source of regenerative cardiomyocytes[J].{H}CIRCULATION RESEARCH,2006,(08):1002-1013.
  • 6Blau HM,Brazelton TB,Weimann JM. The evolving concept of a stem cel:entity or function[J].Cel,2001,(07):829-841.
  • 7Orlic D,Hil JM,Arai AE. Stem cel s for myocardial regeneration[J].{H}CIRCULATION RESEARCH,2002,(12):1092-1102.
  • 8Ryu JH,Kim IK,Cho SW. Implantation of bone marrow mononuclear cel s using injectable fibrin matrixenhances neovascularization in infarcted myocardium[J].{H}BIOMATERIALS,2005,(03):319-326.
  • 9Carnieto A Jr,Dourado PM,da Luz PL. Selective cyclooxygenase-2 inhibition protects against myocardial damage in experimental acute ischemia[J].Clinics (Sao Paulo),2009,(03):245-252.
  • 10Pittenger MF,Mackay AM,Beck SC. Multilineage potential of adult human mesenchymal stem cel s[J].{H}SCIENCE,1999,(5411):143-147.

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部